Cross Shawn
SEC-identified person · CIK 1734779 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Pacira Pharmaceuticals, Inc. PCRX | Chief Financial Officer | filed 2024 - 2026 |
| Cyclo Therapeutics, Inc. CYTH | Director | filed 2023 - 2025 |
| Applied Molecular Transport Inc. AMTI | Director · President & COO | filed 2020 - 2023 |
| Bioplus Acquisition Corp. BIOS | Director | filed 2021 - 2021 |
| Oxis International INC oxis.ob | Director · Chief Executive Officer | filed 2018 - 2018 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.